pharmaceutical investing Vertex Announces Northern Ireland Offer Accepted for Cystic Fibrosis Treatments
Health Canada Approves PrSYMDEKO (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis
Homerun Resources Inc. Announces Multi-Process Testing Results for Santa Maria Eterna High-Purity Silica Sand Project
